The Modesto Bee Local Stock Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Blog posts about
 
< Previous 1 2 Next >
PRX Relaunches Its iPhone App, Now Lets You Download All Your Favorite Public Radio Programs
February 11, 2013
The Public Radio Player app for the iPhone has been a round for a while now, but today, Cambridge-based Public Radio Exchange (PRX) is relaunching the app with a revamped visual design, new interface... Read More
category TC , prx , NPR , and 1 more.
from TechCrunch
West meets east: Silicon Valley accelerator to tackle the future of journalism
December 03, 2012
An unlikely startup accelerator has cropped up in San Francisco Monday, aimed at tackling the big problems in journalism and media from a Silicon Valley perspective, where entrepreneurs aim to change... Read More
category public media , Evan Williams , Corey Ford , and 4 more.
from GigaOM
(RDY) Dr. Reddy’s Laboratories Launches Generic Toprol
September 13, 2012
Dr. Reddy’s Laboratories (RDY) recently announced the launch of its generic version of... Visit StockBlogHub to view complete post. Read More
category Par Pharmaceutical Companies Inc , Mylan Inc/ , Glaxosmithkline plc , and 17 more.
from Stock Blog Hub
(PRX) Par Pharmaceuticals Companies to be Aquired by TPG
August 21, 2012
Yet another acquisition agreement was recently announced in the pharma sector. US based specialty... Visit StockBlogHub to view complete post. Read More
category Par Pharmaceutical Companies Inc , AMLN , Glaxosmithkline plc , and 9 more.
from Stock Blog Hub
Downgrades: BPI, DRQ, GLCH, PRX, RAX
August 08, 2012
New York, August 8th (TradersHuddle.com) – Following are some of the analysts’ downgrades before the market open. Bridgepoint Education (NYSE: BPI</. Read More -- Read More
from TradersHuddle.com
Par Pharmaceutical Companies, Inc. (NYSE:PRX) Stockholder Files Lawsuit to Block Buyout
July 30, 2012
San Diego, CA -- (SBWIRE) -- 07/30/2012 -- A lawsuit was filed for current NYSE:PRX stockholders in effort to stop the proposed takeover of Pharmaceutical Companies, Inc. and current NYSE:PRX... Read More
from SBWire - Latest Press Releases
How Kickstarter could disrupt public radio
July 18, 2012
This week, public radio's Blank on Blank successfully raised more than $11,000 in funding on Kickstarter. It's not the only radio show looking to crowdfunding as a new way to connect to its audience,... Read More
category public media , David Gerlach , public radio , and 1 more.
from GigaOM
(ALNY) Company News for July 17, 2012 – Corporate Summary
July 17, 2012
• Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) surged 53% following positive results... Visit StockBlogHub to view complete post. Read More
category Par Pharmaceutical Companies Inc , GCI , Gardner Denver Inc/ , and 9 more.
from Stock Blog Hub
Model benefits from strong healthcare gains
May 17, 2012
The month of April was kind to the Healthcare Model. Read More
category SQNM , HSTM , CNC , and 7 more.
from Smarter Investing
New Analyst Coverage
April 20, 2012
New York, April 20th (TradersHuddle.com) - Following are some of the new analyst ratings before the market open. Finish Line ( NASDAQ:FINL ) was initiated with a Buy and a target price of $27 at The... Read More
from TradersHuddle.com
Par Pharma Acquires Handa’s ANDA
April 20, 2012
Par Pharmaceutical Companies Inc. (NYSE:PRX) recently entered into an agreement with Handa Pharmaceuticals, according to which Par Pharma acquired the abbreviated new drug application (ANDA) for... Read More
category Stocks , External Research , Contributor
from DailyMarkets.com
Par Pharma Launches Generic Provigil
April 11, 2012
Par Pharmaceutical Companies Inc. (NYSE:PRX) recently announced that it has commenced the shipment of a generic version of Provigil, approved for improving wakefulness in patients with excessive... Read More
category PRX , TEVA , Stocks , and 2 more.
from DailyMarkets.com
PRX Outperforms; Reaffirms Guidance
March 05, 2012
Par Pharmaceutical Companies Inc. (NYSE:PRX) posted fourth quarter 2011 adjusted earnings of 78 cents per share, above the Zacks Consensus Estimate of 75 cents and the year-ago earnings of 61 cents per... Read More
category PRX , AZN , Stocks , and 2 more.
from DailyMarkets.com
Par Pharma Absorbs Edict Pharma
February 22, 2012
Par Pharmaceutical Companies Inc. (NYSE:PRX) recently announced that it has completed the acquisition of India-based generic company Edict Pharmaceuticals. Par Pharma paid $20.5 million at the close of... Read More
category Stocks , External Research , Contributor
from DailyMarkets.com
Par Pharma Forecasts Robust Growth
January 12, 2012
Par Pharmaceuticals Inc. (NYSE:PRX) held its analyst day recently, where it highlighted its performance in 2011 and also provided a peek into expectations for 2012 and beyond. 2011: The Year That Was…... Read More
category PRX , TEVA , Stocks , and 2 more.
from DailyMarkets.com
Par Pharma Takes Over Anchen Pharma
November 18, 2011
Par Pharmaceutical Companies Inc. (NYSE:PRX) recently announced the completion of the acquisition of privately-held Anchen Pharmaceuticals. In August this year, Par Pharma had entered into a definitive... Read More
category PRX , TEVA , Stocks , and 2 more.
from DailyMarkets.com
EPS, Revenues Decline At Par Pharma
November 04, 2011
Par Pharmaceutical Companies Inc. (NYSE:PRX) posted adjusted earnings of 74 cents per share during the third quarter fiscal 2011, in line with the Zacks Consensus Estimate, but below the year-ago... Read More
category PRX , AZN , TEVA , and 3 more.
from DailyMarkets.com
Stock Market News Briefs: AMR, AutoNation, The Blackstone Group L.P., Cephalon, Cisco Systems, New Oriental Education & Technology Group, KeyCorp, Lam Research, Macy’s Inc, Pharmaceutical Resources, T
October 21, 2011
    Blackstone Group (NYSE:BX) posted a Q3 loss of $0.31 per share, lower than the Zacks Consensus Estimate of $0.05 per share     KeyCorp (NYSE:KEY) reported Q3 EPS of $0.24, surpassing the Zacks... Read More
category KEY , TEVA , AAR , and 12 more.
from DailyMarkets.com
Par Pharma Buys From Teva
October 20, 2011
Par Pharmaceutical Companies Inc. (NYSE:PRX) recently announced that it has acquired rights to three products from Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), following the latter’s acquisition... Read More
category PRX , TEVA , Stocks , and 2 more.
from DailyMarkets.com
Teva Acquires Cephalon
October 17, 2011
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) completed the acquisition of Cephalon, Inc. recently. The acquisition agreement had been initially announced in early May 2011. Conditions Laid Down by... Read More
category PRX , TEVA , Stocks , and 2 more.
from DailyMarkets.com
Teva A Step Closer To Cephalon
October 11, 2011
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a step closer to acquiring Cephalon, Inc. (NASDAQ:CEPH) with the US Federal Trade Commission (FTC) accepting the proposed consent order in... Read More
category PRX , TEVA , Stocks , and 3 more.
from DailyMarkets.com
(MYL) Mylan Settles with Roche for Xeloda
September 23, 2011
Mylan Inc. (MYL) recently announced that it has entered into a settlement and license agreement... Visit StockBlogHub to view complete post. Read More
category Watson Pharmaceuticals Inc/ , Par Pharmaceutical Companies Inc , Mylan Inc/ , and 9 more.
from Stock Blog Hub
Mylan Settles With Roche For Xeloda
September 22, 2011
Mylan Inc. (NYSE:MYL) recently announced that it has entered into a settlement and license agreement with Roche (RHHBY) bringing an end to its ongoing litigation with the latter relating to Roche’s... Read More
category PRX , NVS , RHHBY , and 6 more.
from DailyMarkets.com
(MYL) Mylan Analyst Reaffirms Shares at Neutral
August 25, 2011
We have maintained our Neutral recommendation on Mylan Inc. (MYL) with a target price of $19.00... Visit StockBlogHub to view complete post. Read More
category Par Pharmaceutical Companies Inc , Mylan Inc/ , TEVA , and 13 more.
from Stock Blog Hub
Par Pharmaceutical (PRX) to acquire Anchen Pharmaceuticals for $410 million in cash
August 24, 2011
Par Pharmaceutical Companies Inc. (NYSE: PRX), developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States announced today that it entered into a... Read More
category PRX , Par Pharmaceutical Companies Inc/ , Healthcare Pharmaceuticals Stock Market
from CEOWORLD Magazine
(MYL) Mylan and Endo Pharmaceuticals in Legal Tussle
August 18, 2011
Mylan Inc. (MYL) recently announced that Endo Pharmaceuticals (ENDP) filed a patent infringement... Visit StockBlogHub to view complete post. Read More
category Par Pharmaceutical Companies Inc , Mylan Inc/ , TEVA , and 15 more.
from Stock Blog Hub
(MYL) Mylan Beats Second Quarter Earnings on All Fronts
July 28, 2011
Mylan Inc.’s (MYL) second quarter 2011 earnings (excluding special items) of 52 cents per share... Visit StockBlogHub to view complete post. Read More
category Par Pharmaceutical Companies Inc , Mylan Inc/ , TEVA , and 15 more.
from Stock Blog Hub
(MYL) Mylan Gets HIV Rights from Gilead
July 14, 2011
Mylan, Inc. (MYL) recently announced that its Indian subsidiary Matrix Laboratories has been granted future rights to produce and sell generic versions of three investigational HIV therapies of Gilead... Read More
category Par Pharmaceutical Companies Inc , Mylan Inc/ , TEVA , and 13 more.
from Stock Blog Hub
Mylan Gets HIV Rights From Gilead
July 13, 2011
Mylan, Inc. (NYSE:MYL) recently announced that its Indian subsidiary Matrix Laboratories has been granted future rights to produce and sell generic versions of three investigational HIV therapies of... Read More
category TEVA , External Research , Contributor , and 7 more.
from DailyMarkets.com
(PRX) Par Pharmaceutical Restructures Branded Business
July 05, 2011
Par Pharmaceutical Companies, Inc. (PRX) is in for a strategic assessment as it announced restructuring plans for its branded drugs segment, Strativa Pharmaceuticals. The company will reduce its... Read More
category PRX , Par Pharmaceutical Companies Inc , AZN , and 3 more.
from Stock Blog Hub
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here